S91.252

⚠ Non-billable (Header)

Open bite of left great toe with damage to nail

Injury, poisoning and certain other consequences of external causes (S00-T88)

⚠️ This is a category header code — not billable. Use a more specific child code below.

Check This Code

❌ Excludes1

inherited

Rules inherited from parent codes in the hierarchy.

  • superficial bite of toe (S90.46-, S90.47-)
  • open fracture of ankle, foot and toes (S92.-with 7th character B)
  • traumatic amputation of ankle and foot (S98.-)

Clinical Description

ICD-10-CM code S91.252 represents open bite of left great toe with damage to nail. This code falls under the Injury, poisoning and certain other consequences of external causes (S00-T88) classification. It is a non-billable category header code. A more specific child code from the list below must be used for billing and reimbursement purposes.

This is a 7-character code at the 6th level of specificity. There are 3 more specific child codes under S91.252. Coders should note that S91.252 has 3 Excludes1 restriction(s) — codes that cannot be reported together on the same claim.

Frequently Asked Questions

What is ICD-10 code S91.252?

ICD-10-CM code S91.252 is "Open bite of left great toe with damage to nail". It belongs to the category: Injury, poisoning and certain other consequences of external causes (S00-T88).

Is S91.252 a billable ICD-10 code?

No, S91.252 is a non-billable header code. A more specific child code must be used for billing.

What codes are excluded with S91.252?

S91.252 has 3 Excludes1 rule(s). These codes are mutually exclusive and cannot be coded together on the same claim.

🧪 Validate Combinations

Add S91.252 to the Excludes Checker to validate against your full code list.

Open in Checker →

Code Information

CodeS91.252
BillableNo — Header code
ParentS91.25
CategoryInjury, poisoning and certain other consequences of external causes (S00-T88)
Excludes13 rule(s)
Excludes20 note(s)
Child codes3

Data Source

CMS ICD-10-CM 2026 Tabular List

Updated October 1, 2025 (FY2026)